Cargando…
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863328/ https://www.ncbi.nlm.nih.gov/pubmed/35217106 http://dx.doi.org/10.1016/j.jinf.2022.02.022 |
_version_ | 1784655217433772032 |
---|---|
author | de Michelena, Paula Torres, Ignacio Ramos-García, Ángela Gozalbes, Victoria Ruiz, Nidia Sanmartín, Ana Botija, Pilar Poujois, Sandrine Huntley, Dixie Albert, Eliseo Navarro, David |
author_facet | de Michelena, Paula Torres, Ignacio Ramos-García, Ángela Gozalbes, Victoria Ruiz, Nidia Sanmartín, Ana Botija, Pilar Poujois, Sandrine Huntley, Dixie Albert, Eliseo Navarro, David |
author_sort | de Michelena, Paula |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8863328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88633282022-02-23 Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant de Michelena, Paula Torres, Ignacio Ramos-García, Ángela Gozalbes, Victoria Ruiz, Nidia Sanmartín, Ana Botija, Pilar Poujois, Sandrine Huntley, Dixie Albert, Eliseo Navarro, David J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-05 2022-02-22 /pmc/articles/PMC8863328/ /pubmed/35217106 http://dx.doi.org/10.1016/j.jinf.2022.02.022 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor de Michelena, Paula Torres, Ignacio Ramos-García, Ángela Gozalbes, Victoria Ruiz, Nidia Sanmartín, Ana Botija, Pilar Poujois, Sandrine Huntley, Dixie Albert, Eliseo Navarro, David Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title | Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title_full | Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title_fullStr | Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title_full_unstemmed | Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title_short | Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant |
title_sort | real-life performance of a covid-19 rapid antigen detection test targeting the sars-cov-2 nucleoprotein for diagnosis of covid-19 due to the omicron variant |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863328/ https://www.ncbi.nlm.nih.gov/pubmed/35217106 http://dx.doi.org/10.1016/j.jinf.2022.02.022 |
work_keys_str_mv | AT demichelenapaula reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT torresignacio reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT ramosgarciaangela reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT gozalbesvictoria reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT ruiznidia reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT sanmartinana reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT botijapilar reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT poujoissandrine reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT huntleydixie reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT alberteliseo reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant AT navarrodavid reallifeperformanceofacovid19rapidantigendetectiontesttargetingthesarscov2nucleoproteinfordiagnosisofcovid19duetotheomicronvariant |